DavidAWilliamsMD
Pediatric Hematology & Oncology • Boston, MALeland Fikes Professor of Pediatrics, Boston Children's Hospital
Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Karp 8
Boston, MA 02115Phone+1 617-919-2697Fax+1 617-730-0934
Summary
- Chief Scientific Officer and SVP for Research; Chief of Hematology/Oncology, Boston Children's Hospital
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1982 - 1987
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1979 - 1982
Indiana University School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1982 - 2025
OH State Medical License 1980 - 2009
IN State Medical License 1979 - 2003- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2002
- Elected Member The American Society for Clinical Investigation, 1993
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Multicenter Phase II Trial-Hematopoietic Stem Cell Transplantation for Treatment of Patients With FA Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine Start of enrollment: 2009 Apr 01
- Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector Start of enrollment: 2010 Apr 01
- Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell disease.Kevyn L Hart, Boya Liu, Devin Brown, Beatriz Campo-Fernandez, Kevin Tam
Molecular Therapy. Methods & Clinical Development. 2024-06-13 - 13 citationsClonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.Michael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu, Erica B Esrick, Emily Mitchell
Nature Medicine. 2023-12-01 - 11 citationsOutcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.Roxane Labrosse, Julia I Chu, Myriam A Armant, John K Everett, Danilo Pellin
Blood. 2023-10-12
Abstracts/Posters
- Investigation of Cell-Contact Dependent Alterations in Immune Synapse Formation between T Cells and BCP-ALL CellsDavid A Williams, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich SyndromeDavid A Williams, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Gene Therapy Offers Huge Potential for Combating Disease, Doctors SayMay 31st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
